BIMI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BIMI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. BIMI International Medical's Revenue for the three months ended in Sep. 2023 was $2.52 Mil. BIMI International Medical's Total Assets for the quarter that ended in Sep. 2023 was $35.85 Mil. Therefore, BIMI International Medical's Asset Turnover for the quarter that ended in Sep. 2023 was 0.07.
Asset Turnover is linked to ROE % through Du Pont Formula. BIMI International Medical's annualized ROE % for the quarter that ended in Sep. 2023 was -127.75%. It is also linked to ROA % through Du Pont Formula. BIMI International Medical's annualized ROA % for the quarter that ended in Sep. 2023 was -34.91%.
The historical data trend for BIMI International Medical's Asset Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIMI International Medical Annual Data | |||||||||||||||||||||
Trend | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | |||||||||||
Asset Turnover | Get a 7-Day Free Trial | - | - | 0.41 | 0.60 | 0.32 |
BIMI International Medical Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Asset Turnover | Get a 7-Day Free Trial | 0.14 | 0.04 | 0.09 | 0.15 | 0.07 |
For the Pharmaceutical Retailers subindustry, BIMI International Medical's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, BIMI International Medical's Asset Turnover distribution charts can be found below:
* The bar in red indicates where BIMI International Medical's Asset Turnover falls into.
Asset Turnover measures how quickly a company turns over its asset through sales.
BIMI International Medical's Asset Turnover for the fiscal year that ended in Dec. 2022 is calculated as
Asset Turnover | ||||||
= | Revenue | / | Average Total Assets | |||
= | Revenue (A: Dec. 2022 ) | / | ( (Total Assets (A: Dec. 2021 ) | + | Total Assets (A: Dec. 2022 )) | / count ) |
= | 11.83 | / | ( (38.128 | + | 35.714) | / 2 ) |
= | 11.83 | / | 36.921 | |||
= | 0.32 |
BIMI International Medical's Asset Turnover for the quarter that ended in Sep. 2023 is calculated as
Asset Turnover | ||||||
= | Revenue | / | Average Total Assets | |||
= | Revenue (Q: Sep. 2023 ) | / | ( (Total Assets (Q: Jun. 2023 ) | + | Total Assets (Q: Sep. 2023 )) | / count ) |
= | 2.523 | / | ( (36.658 | + | 35.041) | / 2 ) |
= | 2.523 | / | 35.8495 | |||
= | 0.07 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.
BIMI International Medical (NAS:BIMI) Asset Turnover Explanation
Asset Turnover is linked to ROE % through Du Pont Formula.
BIMI International Medical's annulized ROE % for the quarter that ended in Sep. 2023 is
ROE %** | (Q: Sep. 2023 ) | ||||
= | Net Income | / | Total Stockholders Equity | ||
= | -12.516 | / | 9.797 | ||
= | (Net Income / Revenue) | * | (Revenue / Total Assets) | * | (Total Assets / Total Stockholders Equity) |
= | (-12.516 / 10.092) | * | (10.092 / 35.8495) | * | (35.8495/ 9.797) |
= | Net Margin % | * | Asset Turnover | * | Equity Multiplier |
= | -124.02 % | * | 0.2815 | * | 3.6592 |
= | ROA % | * | Equity Multiplier | ||
= | -34.91 % | * | 3.6592 | ||
= | -127.75 % |
Note: The Net Income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.
It is also linked to ROA % through Du Pont Formula:
BIMI International Medical's annulized ROA % for the quarter that ended in Sep. 2023 is
ROA % | (Q: Sep. 2023 ) | ||
= | Net Income | / | Total Assets |
= | -12.516 | / | 35.8495 |
= | (Net Income / Revenue) | * | (Revenue / Total Assets) |
= | (-12.516 / 10.092) | * | (10.092 / 35.8495) |
= | Net Margin % | * | Asset Turnover |
= | -124.02 % | * | 0.2815 |
= | -34.91 % |
Note: The Net Income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.
Thank you for viewing the detailed overview of BIMI International Medical's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Ang Sammi Ean Seok | director | 2658 VISTA MONTE CIRCLE, CHINO HILLS CA 91709 |
Fnu Oudom | director | 7700 IRVINE CENTRE DRIVE, SUITE 800, IRVINE CA 92618 |
Xiaoping Wang | director | ROOM 4-6,NO.88-4 HUAYAN FIRST VILLAGE, SHAPINGBA DISTRICT, CHONGQING F4 400037 |
Baiqun Zhong | officer: CFO | 1-7, NO.27, HUAYAN NEW VILLAGE, JIULONGPO DISTRICT, CHONGQING F4 400039 |
Zhang Tingting | director, officer: Chief Financial Officer | 3708, FULI CENTER, NO.6 GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001 |
Song Tiewei | director | 17 FLOOR, FULI CENTER NO.6,GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001 |
Yongquan Bi | 10 percent owner | ROOM 3708, WANDA PLACE, 6 GANGWAN ROAD, ZHONGSHAN DISTRICT, DALIAN CITY, LIAONING PROVINCE F4 116001 |
Wang Lihua | director, 10 percent owner, officer: Chief Financial Officer | NO 4 4 12 58 BAJING ROAD, HEPING DISTRICT SHENYANG CITY, LIAONING PROVINCW F4 110003 |
Li Gang | director, 10 percent owner, officer: President and CEO | 19B3 62 WEST HINHE ROAD, SHENHE DISTRICT SHENYANG CITY, LIAONING PROVINCE F4 110000 |
Jiuding Yan | director | C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021 |
Lesley Jin | director | C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021 |
Maclean John Coleman | director | 112 E 4TH AVE, SUITE 206, OLYMPIA WA 98501 |
Zhongmin Wang | director | C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021 |
Jianxin Wang | director | C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021 |
Mia Kuang Ching | director | C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 05-18-2022
By PurpleRose PurpleRose • 07-11-2022
By Marketwired • 08-07-2023
By GuruFocusNews GuruFocusNews • 06-30-2022
By GuruFocusNews GuruFocusNews • 07-01-2022
By GuruFocusNews GuruFocusNews • 06-20-2022
By GuruFocusNews GuruFocusNews • 07-08-2022
By GuruFocusNews GuruFocusNews • 06-27-2022
By Value_Insider Value_Insider • 12-08-2022
By GuruFocusNews GuruFocusNews • 07-07-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.